Base de dados : HANSEN
Pesquisa : NEOPLASIAS CUTANEAS/FISIOPATOL [Descritor de assunto]
Referências encontradas : 8 [refinar]
Mostrando: 1 .. 8   no formato [Detalhado]

página 1 de 1

  1 / 8 HANSEN  
              next record last record
seleciona
para imprimir
Id:25234
Autor:Toyama, Ikuzo
Título:Sobre o aparecimento do CA da pele no leproso
On the appearance of the CA of the skin in the leper-
Fonte:s.l; s.n; 1913. 6 p. ilus.
Resumo:É já conhecido que o aparecimento de um CA. no leproso, especialmente, se desenvolve da ulceração leprosa para tumor CA e nessa ocasião, o tecido patologico multiplica-se mielomamente ou papilomatosamente, do fundo da lesão, destruindo os tecidos normais e se faz metastases aos ganglios visinhos. (AU).
Descritores:NEOPLASIAS CUTÂNEAS/compl
NEOPLASIAS CUTÂNEAS/diag
NEOPLASIAS CUTÂNEAS/fisiopatol
NEOPLASIAS CUTÂNEAS/cirurg
HANSENIASE/compl
HANSENIASE/diag
HANSENIASE/genet
HANSENIASE/fisiopatol
Limites:ESTUDO COMPARATIVO
Localização:BR191.1; 04548/s


  2 / 8 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:24658
Autor:Sociedade Brasileira de Dermatologia*.
Título:Câncer da pele: notícias veiculadas na imprensa
Skin neoplasms: information in the press-
Fonte:Rio de Janeiro; s.n; 2006. 39 p. ilus.
Descritores:NEOPLASIAS CUTÂNEAS/epidemiol
NEOPLASIAS CUTÂNEAS/prev
NEOPLASIAS CUTÂNEAS/fisiopatol
NEOPLASIAS CUTÂNEAS/reabil
NEOPLASIAS CUTÂNEAS/terap
Limites:RELATO DE CASO
HUMANO
Localização:BR191.1; 01124/f


  3 / 8 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:24648
Autor:Geller AC; Swetter SM; Brooks K; Demierre MF; Yaroch AL
Título:Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions
..-
Fonte:s.l; s.n; 2007. ^l555^f572 p. tab, graf.
Resumo:In the past 5 years, there have been notable strides toward the earlier recognition and discovery of melanoma, including new technologies to complement and augment the clinical examination and new insights to help clinicians recognize early melanoma. However, incidence and mortality rates throughout most of the developed world have risen over the past 25 years, while education and screening, potentially the best means for reducing the disease, continue to be severely underutilized. Much progress needs to be made to reach middle-aged and older men and persons of lower socioeconomic status who suffer a disproportionate burden of death from melanoma. Worldwide melanoma control must also be a priority, and comprehensive educational and screening programs should be directed to Northern Ireland and a number of Eastern European nations, whose 5-year survival rates range between 53% and 60%, mirroring those of the United States and Australia more than 40 years ago. LEARNING OBJECTIVE: After completing this learning activity, participants should be aware of the most recent melanoma epidemiologic data, both in the United States and internationally; worldwide early detection and screening programs; clinical strategies to recognize and improve the detection of early melanoma; the latest technologies for early detection of melanoma; and public and professional education programs designed to enhance early detection.(AU).
Descritores:MELANOMA/epidemiol
MELANOMA/genet
MELANOMA/fisiopatol
DERMATOPATIAS/compl
DERMATOPATIAS/epidemiol
DERMATOPATIAS/genet
DERMATOPATIAS/microbiol
DERMATOPATIAS/fisiopatol
DERMATOPATIAS/cirurg
NEOPLASIAS CUTÂNEAS/compl
 NEOPLASIAS CUTÂNEAS/epidemiol
 NEOPLASIAS CUTÂNEAS/imunol
 NEOPLASIAS CUTÂNEAS/microbiol
 NEOPLASIAS CUTÂNEAS/fisiopatol
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1; 00337/cme


  4 / 8 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:24490
Autor:Wilkins K; Turner R; Dolev JC; LeBoit PE; Berger TG; Maurer TA
Título:Cutaneous malignancy and human immunodeficiency virus disease
Cutaneous malignancy and human immunodeficiency virus disease-v.54
Fonte:s.l; s.n; 2006. 17 p. tab.
Resumo:Certain skin cancers occur with increased frequency or altered course in patients infected with HIV. Malignant melanoma and squamous cell carcinoma are examples of cutaneous malignancies that have a more aggressive course in patients with HIV. Others, such as basal cell carcinoma, appear more frequently in this population but do not appear to be more aggressive. The incidence of HIV-associated Kapsosi's sarcoma has markedly decreased since the advent of HIV antiretroviral therapy. Our understanding of the pathogenesis of this malignancy and its unique management issues are fully reviewed. Cutaneous T-cell lymphoma (CTCL) is rare in this population. Other types of cutaneous lymphoma and HIV-associated pseudo-CTCL are discussed. This article addresses prevention, treatment, and follow-up strategies for this at-risk population. LEARNING OBJECTIVE: At the completion of this learning activity, participants should be familiar with the unique epidemiology, clinical course, and management of cutaneous malignancy in patients infected with HIV...(AU.
Descritores:NEOPLASIAS CUTÂNEAS/genet
NEOPLASIAS CUTÂNEAS/microbiol
NEOPLASIAS CUTÂNEAS/fisiopatol
NEOPLASIAS CUTÂNEAS/virol
LINFOMA/genet
LINFOMA/fisiopatol
LINFOMA/virol
MELANOMA/fisiopatol
MELANOMA/virol
CARCINOMA/fisiopatol
 CARCINOMA/virol
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1; 00318/cme


  5 / 8 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:24487
Autor:Wright TI; Spencer JM; Flowers FP
Título:Chemoprevention of nonmelanoma skin cancer
Chemoprevention of nonmelanoma skin cancer-v.54
Fonte:s.l; s.n; 2006. 13 p. ilus, tab.
Resumo:Skin cancer is the most common cancer in human beings. The increased incidence of skin cancer has brought much attention to the process by which these tumors develop and how they can be prevented. Efforts have been made to educate the public about the importance of protecting skin from excessive ultraviolet light. Despite this work, the incidence of skin cancer continues to increase. Available compounds may be useful in the chemoprevention of skin cancer. Chemoprevention is defined as oral or topical use of dietary or pharmacologic agents to inhibit or reverse the development of cancer. Potential agents included are the retinoids; difluoromethylornithine; T4 endonuclease V; polyphenolic antioxidants, such as (-)-epigallocatechin gallate, found in green tea and grape seed extract; silymarin; isoflavone genestein; nonsteroidal anti-inflammatory drugs; curcumin; lycopene; vitamin E; beta-carotene; and selenium. Many of these agents are available over the counter as topical or oral preparations. LEARNING OBJECTIVE: At the conclusion of this activity, participants should be familiar with the chemopreventive agents and their efficacy, as well as any significant side effects associated with them...(AU).
Descritores:NEOPLASIAS CUTÂNEAS/quimioter
NEOPLASIAS CUTÂNEAS/genet
NEOPLASIAS CUTÂNEAS/prev
NEOPLASIAS CUTÂNEAS/fisiopatol
NEOPLASIAS CUTÂNEAS/terap
SILIMARINA/sint quim
 SILIMARINA/farmacol
 SILIMARINA/uso terap
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1; 00321/cme


  6 / 8 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:24485
Autor:Izikson L; English JC; Zirwas MJ
Título:The flushing patient: differential diagnosis, workup, and treatment
The flushing patient: differential diagnosis, workup, and treatment-v.55
Fonte:s.l; s.n; 2006. 15 p. ilus.
Resumo:Cutaneous flushing-a common presenting complaint to dermatologists, allergists, internists, and family practitioners-results from changes in cutaneous blood flow triggered by multiple conditions. Most cases are caused by very common, benign diseases, such as rosacea or climacterum, that are readily apparent after a thorough taking of history and physical examination. However, in some cases, accurate diagnosis requires further laboratory, radiologic, or histopathologic studies to differentiate several important clinicopathologic entities. In particular, the serious diagnoses of carcinoid syndrome, pheochromocytoma, mastocytosis, and anaphylaxis need to be excluded by laboratory studies. If this work-up is unrevealing, rare causes, such as medullary carcinoma of the thyroid, pancreatic cell tumor, renal carcinoma, and others, should be considered. LEARNING OBJECTIVE: At the completion of this learning activity, participants should be familiar with the mechanisms of flushing, its clinical differential diagnosis, the approach to establish a definitive diagnosis, and management of various conditions that produce flushing.(AU).
Descritores:DOENCAS DO SISTEMA NERVOSO/compl
DOENCAS DO SISTEMA NERVOSO/diag
DOENCAS DO SISTEMA NERVOSO/fisiopatol
NEOPLASIAS CUTÂNEAS/compl
NEOPLASIAS CUTÂNEAS/genet
NEOPLASIAS CUTÂNEAS/fisiopatol
ACNE ROSACEA/compl
 ACNE ROSACEA/diag
 ACNE ROSACEA/fisiopatol
 NEOPLASIAS/compl
 NEOPLASIAS/fisiopatol
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1; 00323/cme


  7 / 8 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:24483
Autor:Gloster HM; Neal K
Título:Skin cancer in skin of color
Skin cancer in skin of color-v.55
Fonte:s.l; s.n; 2006. 19 p. ilus, tab.
Resumo:Skin cancer is less common in persons with skin of color than in light-skinned Caucasians but is often associated with greater morbidity and mortality. Thus, it is crucial that physicians become familiar with skin cancer in persons of color so as to maximize the likelihood of early detection of these tumors. In dark-skinned ethnic groups, squamous cell carcinoma is most common; squamous cell carcinoma and melanoma usually occur on nonsun-exposed sites; and ultraviolet radiation is not an important etiologic factor for skin cancer with the exception of basal cell carcinoma. Races of intermediate pigmentation, such as Hispanics and Asians, share epidemiologic and clinical features of dark-skinned ethnic groups and Caucasians. Skin cancers pose a significant risk in skin of color and clinicians should focus on preventive measures in these groups such as regular skin exams, self-examination, public education, and screening programs. LEARNING OBJECTIVE: At the completion of this learning activity, participants should be familiar with the epidemiology and unique clinical features of skin cancer in skin of color and be aware of strategies to prevent skin cancer in skin of color.(AU).
Descritores:NEOPLASIAS CUTÂNEAS/quim
NEOPLASIAS CUTÂNEAS/compl
NEOPLASIAS CUTÂNEAS/diag
NEOPLASIAS CUTÂNEAS/genet
NEOPLASIAS CUTÂNEAS/imunol
NEOPLASIAS CUTÂNEAS/prev
NEOPLASIAS CUTÂNEAS/fisiopatol
NEOPLASIAS CUTÂNEAS/reabil
NEOPLASIAS CUTÂNEAS/radioter
NEOPLASIAS CUTÂNEAS/cirurg
NEOPLASIAS CUTÂNEAS/terap
SARCOMA DE KAPOSI/compl
SARCOMA DE KAPOSI/diag
SARCOMA DE KAPOSI/fisiopatol
RAIOS ULTRAVIOLETA/uso diag
 TERAPIA ULTRAVIOLETA/instrum
 TERAPIA ULTRAVIOLETA/métodos
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1; 00326/cme


  8 / 8 HANSEN  
              first record previous record
seleciona
para imprimir
Id:13146
Autor:Drateln, Claudia Reynoso von
Título:Sarcoma de Kaposi en un paciente con lepra lepromatosa VIH negativo
?-
Fonte:s.l; s.n; 1994. 3 p. ilus.
Descritores:SARCOMA DE KAPOSI
NEOPLASIAS CUTANEAS
HANSENIASE LEPROMATOSA
PREDNISONA
AMILOIDOSE
AMILOIDOSE
DAPSONA
CLOFAZIMINA
Localização:BR191.1; 06152/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information